FFNTF (4Front Ventures) Market Cap: $0.01 Mil (As of Jun. 26, 2026)


FFNTF 4Front Ventures Corp FFNTF
10 GF Score
Price $0.00
View Full Analysis

What is 4Front Ventures Market Cap?

4Front Ventures FFNTF -90.00% 10 Market Cap is $0.01 Mil as of Jun. 26, 2026. GuruFocus rates FFNTF with a GF Score™ of 10/100.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). 4Front Ventures's share price for the quarter that ended in Sep. 2024 was $0.045. 4Front Ventures's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 915.20 Mil. Therefore, 4Front Ventures's market cap for the quarter that ended in Sep. 2024 was $41.18 Mil.

4Front Ventures's quarterly market cap declined from Mar. 2024 ($102.39 Mil) to Jun. 2024 ($78.71 Mil) and declined from Jun. 2024 ($78.71 Mil) to Sep. 2024 ($41.18 Mil).

4Front Ventures's annual market cap declined from Dec. 2021 ($600.12 Mil) to Dec. 2022 ($150.24 Mil) and declined from Dec. 2022 ($150.24 Mil) to Dec. 2023 ($66.48 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. 4Front Ventures's Enterprise Value for Today is $212.91 Mil.


4Front Ventures  (OTCPK:FFNTF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


4Front Ventures Market Cap Related Terms


4Front Ventures Market Cap Historical Data

* Premium members only.

The historical data trend for 4Front Ventures's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4Front Ventures Market Cap Chart

4Front Ventures Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 276.64 486.10 600.12 150.24 66.48

4Front Ventures Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 164.79 66.48 102.39 78.71 41.18

FFNTF vs CRYM, PNXP, SKYI: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, 4Front Ventures's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4Front Ventures Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 4Front Ventures's Market Cap distribution charts can be found below:

* The bar in red indicates where 4Front Ventures's Market Cap falls into.


FFNTF
10GF Score
4Front Ventures Corp FFNTF
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4Front Ventures Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

4Front Ventures's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=$0.0993*669.519
=$66.48

4Front Ventures's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=$0.045*915.200
=$41.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.01 Mil mean?
4Front Ventures (FFNTF) has a Market Cap of $0.01 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on 4Front Ventures and its competitors.
Is 4Front Ventures' Market Cap too high?
4Front Ventures' current Market Cap is $0.01 Mil. The Drug Manufacturers industry median Market Cap is 205.37. 4Front Ventures' value of $0.01 Mil is 100% below this industry median. Overall, 4Front Ventures has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does 4Front Ventures' Market Cap compare to CRYM and PNXP?
4Front Ventures' Market Cap of $0.01 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 205.37. 4Front Ventures' value of $0.01 Mil is 100% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 205.37, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 4Front Ventures's current Market Cap of $0.01 Mil is 100% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on 4Front Ventures and its competitors. For the Drug Manufacturers industry, the median Market Cap is 205.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4Front Ventures's current Market Cap is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4Front Ventures stock overvalued right now?
4Front Ventures (FFNTF) has a current Market Cap of $0.01 Mil. The current Market Cap is $0.01 Mil and 100% below the Drug Manufacturers industry median of 205.37. 4Front Ventures' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For 4Front Ventures (FFNTF), the current Market Cap is $0.01 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

4Front Ventures Business Description

Address 7010 E. Chauncey Lane, Suite 235, Phoenix, AZ, USA, 85054
4Front Ventures Corp is a Canadian-based company. It is engaged in the cultivation, processing, extracting, manufacturing, and distribution of cannabis products. It operates in two segments: THC Cannabis and CBD Wellness. The THC Cannabis segment engages in the production and cultivation of THC cannabis, manufacturing and distribution of cannabis products to owned dispensaries and third-party retail customers. The CBD Wellness segment encompasses the production and sale of CBD products to third-party customers.
10GF Score

Get the complete analysis for FFNTF

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price